One CVS Drive
Woonsocket , RI 02895
Woonsocket , RI 02895
News
-
CVS Healthcare declined 7.5% to $58.90 after the drugstore chain announced preliminary third quarter earnings and replaced its chief executive.
The company estimated diluted earnings per share to range between 3 cents and 8 cents and adjusted earnings per share between $1.05 and $1.10.
The company appointed longtime executive David Joyner as the new chief executive and president, replacing Karen Lynch effective October 17.
The drug retailer said it plans to take a restructuring charge of $1.2 billion in the third quarter, related to incre More
Oct 18, 2024 -
CVS Health Corp decreased 9.5% to $66.10 after Blue Shield of California dropped the company's pharmacy services.
The company said it will partner with Cost Plus Drug Company and Amazon pharmacy services to save drug costs for its 5 million members.
Aug 17, 2023
Executive/
Director
Links
Price
- Last Close
-
$ 44.37
$ +0.58 1.32 %
Dec 20, 2024
- 52-Week High/Low
- $81.39 - $53.57
- YTD
- -43.8%
- Trading Volume
- 718,815
- Market Cap Full
- $ 57.1B
- Shares Outstanding
-
1286.9M
Oct 25, 2023
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 7.6% | 6.6% | 0.1% | -13.7% | -19.8% | -5% | 11.3% | -2.3% | -20.3% | 1% |
| Q2 | 2% | -7.3% | 3.2% | 6.2% | 1.5% | 4% | 9.8% | -8.5% | -7% | -7.2% |
| Q3 | -7.7% | -6.6% | 1.7% | 21.7% | 15.9% | 8% | 1.7% | 2.9% | 1% | - |
| Q4 | 1.7% | -10.9% | -9.6% | -17.6% | 18.7% | 17% | 22% | -2.3% | 13.3% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -5.8% | -0.1% | 7.3% | -7.4% | - | - | - | - | - | - | - | - |
| 2023 | -5.4% | -5.3% | -11.1% | -1.3% | -7.1% | 1.5% | 8.1% | -12.7% | 7.1% | -1.2% | -1.6% | 16.2% |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 37% | 3% | -18% | -6% | -11% | 17% | -8% | 52% | -10% | -15% | -44% |
Earnings
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Q1 | 1.14 | 1.18 | 1.17 | 1.48 | 1.62 | 1.53 | 1.68 | 1.74 | 1.65 |
| Q2 | 1.22 | 1.32 | 1.33 | 1.69 | 1.89 | 2.26 | 2.1 | 2.23 | 1.48 |
| Q3 | 1.28 | 1.64 | 1.50 | 1.73 | 1.84 | 0.93 | 1.2 | -2.6 | 1.75 |
| Q4 | 1.53 | 1.71 | 1.92 | 2.14 | - | 0.74 | 0.98 | 1.77 | - |
| A | 5.2 | 5.9 | 5.9 | -0.6 | 5.1 | 5.5 | 6 | 3.14 | 4.88 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Dividend +
Dividend +
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Q1 | 0.50 | 0.50 | 0.50 | 0.55 | 0.61 | 0.67 |
| Q2 | 0.50 | 0.50 | 0.50 | 0.55 | 0.61 | 0.67 |
| Q3 | 0.50 | 0.50 | 0.50 | 0.55 | 0.61 | 0.67 |
| Q4 | 0.50 | 0.50 | 0.50 | 0.55 | 0.61 | 0.67 |
| A | 2 | 2 | 2 | 2.2 | 2.44 | 2.68 |
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Mar | - | 1297.1 | 1304.2 | 1311.4 | 1312.5 | 1284.1 |
| Jun | 1016.6 | 1299.1 | 1307.1 | 1316.6 | 1311.3 | 1282 |
| Sep | 1018.1 | 1300.5 | 1308.7 | 1319.6 | 1312.8 | 1284.4 |
| Dec | 1018.8 | 1301 | 1308.9 | 1320.1 | 1314 | 1286.9 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||||||||||
| Inventory / Stock Turnover | 10.3 | 9.9 | 8.9 | 9.1 | 9.5 | |||||||||||||
| Fixed Asset Turnover | 7.7 | 6.4 | 6.3 | 6.7 | 5.4 | |||||||||||||
| Total Asset Turnover | 1.4 | 1.3 | 1.2 | 1.2 | 1 | |||||||||||||
| Leverage | ||||||||||||||||||
| Debt Ratio | 0.8 | 0.9 | 1.1 | 1.3 | 1.6 | |||||||||||||
| Debt – Equity Ratio | 0.7 | 0.7 | 0.9 | 1 | 1.2 | |||||||||||||
| Interest Coverage | 2.2 | 2.5 | 2.1 | 2.2 | 0.9 | |||||||||||||
| Equity multiplier | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | |||||||||||||